Methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate
C22H29N5O3 — CID 95785053
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate
Methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate (PubChem CID 95785053) has the molecular formula C22H29N5O3 and a molecular weight of 411.51 g/mol. Its IUPAC name is methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate.
Molecular Properties
| Compound Name | Methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate |
|---|---|
| PubChem CID | 95785053 |
| Molecular Formula | C22H29N5O3 |
| Molecular Weight | 411.51 g/mol |
| Exact Mass | 411.23 |
| IUPAC Name | methyl 2-[4-[[(1S)-3-methyl-1-(2-propoxyphenyl)butyl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]acetate |
| SMILES | CCCOc1ccccc1[C@H](CC(C)C)Nc1ncnc2c1cnn2CC(=O)OC |
| InChI | InChI=1S/C22H29N5O3/c1-5-10-30-19-9-7-6-8-16(19)18(11-15(2)3)26-21-17-12-25-27(13-20(28)29-4)22(17)24-14-23-21/h6-9,12,14-15,18H,5,10-11,13H2,1-4H3,(H,23,24,26)/t18-/m0/s1 |
| InChIKey | JRADJJGGCKXNJW-SFHVURJKSA-N |
| XLogP | 3.99 |
| TPSA | 91.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.51 |
| LogP ≤ 5 | 3.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 95785053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.